Project co-funded by CDTI — EIC Seal of Excellence
PlusVitech has been awarded a grant from the Centre for the Development of Industrial Technology (CDTI), under the Seal of Excellence of the European Innovation Council (EIC) programme, co-financed by the European Regional Development Fund (ERDF) of the European Union within Spain’s Pluriregional Operational Programme 2021-2027.
Project description
The project focuses on the research and development of innovative therapeutic treatments, combining drug repositioning and nanotechnology, with the aim of offering effective, safe, and accessible solutions for oncology patients.
Objectives
- Advance clinical research into new therapeutic treatments
- Develop innovative nanotechnology-based formulations
- Contribute to access to affordable therapies for patients with no other therapeutic options
Project details
- Beneficiary: PlusVitech S.L.
- CDTI funding (non-repayable): 2,500,000 EUR
- Programme: EIC Seal of Excellence — ERDF 2021-2027
- Thematic objective: Promote research, technological development and innovation
This project has been co-financed by the European Regional Development Fund (ERDF) through the Centre for the Development of Industrial Technology (CDTI), within Spain’s Pluriregional Operational Programme 2021-2027, under the Seal of Excellence of the European Innovation Council programme.